Continuous chemical manufacturing technology has been in use for more than 100 years producing high-volume commodity chemicals. However, it was not until the early 2000s that the technology caught the attention of the pharmaceutical industry in a significant way, and it has since revolutionized the production of pharmaceuticals. In our recent article published in European Pharmaceutical Review, Matthew Bio, Chief Scientific Officer at Cambrex, discusses how continuous manufacturing has become integral to the pharmaceutical industry. Read the full article here: https://lnkd.in/eBp4nxn2
About us
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance development and manufacturing across the entire drug lifecycle, as well as comprehensive analytical and IND enabling services. With over 40 years of experience and a growing team of over 2,000 experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing.
- Website
-
http://www.cambrex.com
External link for Cambrex
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- East Rutherford, New Jersey
- Type
- Privately Held
- Specialties
- Drug substance services, Drug product services, and Analytical services
Locations
Employees at Cambrex
-
Alex Duran
-
Dottie Donnelly Brienza
CHRO | C-Suite Leadership Alignment | Culture Building | HR Strategy | Talent Management | M&A | Change Management | OD
-
Rob Duncan
Senior Talent Acquisition Partner at Cambrex; seeking talent in Quality Control, Analytical Development, Chemical Development, Commercial, and…
-
Cara Wykowski
Director, Business DevelopmentCertified at Cambrex; Certified Peer to Peer Grief Educator
Updates
-
Peptide crystallization introduces greater complexity due to molecular flexibility and size. Each peptide requires unique insight to optimize individual conditions. Trust the team at Cambrex to deliver reliable, scalable results. We leverage the right tools with the best experts to bridge success from the bench to the plant. Learn more here: https://lnkd.in/gbn7K3t5 #peptides #crystallization #pharma
CDMO | Peptide Crystallization | Cambrex
https://www.cambrex.com
-
This summer has been packed with great activities. Our sites have volunteered in their local communities, held a padel competition and an Around the World themed Safety Day, and welcomed Seamus White to the Cambrex Team supporting our partners in the UK and Ireland. We participated at #BIO2024 and #BOSBasel24. Presented at #AIChE Process Development Symposium, #GordonResearchConference Organic Reactions and Processes and the upcoming #ACSFall 2024 Meeting. Looking forward to the remaining of the summer!
-
+2
-
At Cambrex, we understand the critical importance of testing for potential microbiological contaminations and the ultimate impact on patient safety. Trusting the right partner for your testing programs means finding a lab that provides not only comprehensive quality data but also timely and effective solutions to any challenges that you face. Discover how the experts at Cambrex ensure microbiological testing safety across a range of processes for our customers: https://lnkd.in/g-RJrej7 #microbiology #pharma
CDMO | Microbiology | Cambrex
https://www.cambrex.com
-
As part of our video series, “A Different Brand of Experts,” we invite you to meet Kelly McGuill, Microbiology Analyst IV, based in Agawam, Massachusetts. Originally an environmental monitoring, safety and testing expert, Kelly pivoted to microbiology and now assists clients with compendium, release, and sterility testing, disinfectant qualifications, microbial limits testing, endotoxin testing, mycoplasma, and daily water testing. During her interview, Kelly shared, "We have to be very observant with the products that we test. Our job is to ensure we avoid contamination or false positives — both are costly and impact timelines. Every test is treated as if the future of the molecule depends on it." Read her full interview here: https://lnkd.in/emUmCvCf
-
We're excited to be part of Gordon Research Conferences: Organic Reactions and Processes this week. Hear from Parin Shah, Ph.D., Principal Scientist I, Chemical Development, discuss application of a DoE approach for a multi-step manufacturing process, including identification of proven acceptable ranges (PAR) and critical process parameters (CPP).
-
We invite you to connect with our #Recruiting team and local Cambrex scientists at these upcoming events. Learn more about Cambrex and our open positions. We look forward to seeing you there. American Chemical Society - ACS National Fall Meeting ->18-22 August -> https://lnkd.in/gRZiCcEe Iowa State University - Engineering Career Fair -> 18 September -> https://lnkd.in/efXzecZ NC BioNetwork - BioNetwork Fall Career Fair -> 26 September -> https://lnkd.in/eEpBMRT #PharmaCareers #Hiring #CareersAtCambrex
-
At Cambrex, our project managers are instrumental in the delivery of our services. We recently hosted our second annual Project Management Workshop in Charles City, IA, bringing together our PMs from Durham and Charles City. Together, the project managers reflected on the past year's best practices and lessons learned, while charting the next phase of our continuous improvement plan. With customers at the core of everything we do, we will continue to enable our customers to develop and deliver therapeutic solutions that improve the quality of life for patients around the world. Jeff Rommel, James Jarvis, Elena Bejan, MBA, Ph.D., Len Trem, Courtney Hislip, EMBA, Kelly Lane, Jarrett Nisley, David R. Adams
-
It was a beautiful night for baseball. Cambrex hosted its second annual Pharmaceutical Industry Appreciation Night at Fenway Park, celebrating local pharma and biotech innovators for their contributions and dedication to bringing new treatments to patients worldwide. Thank you to everyone who came out to make this event a success.
-
What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction? In Pharma's Almanac's roundtable, Matthew Bio, Chief Scientific Officer at Cambrex, pointed out that the pharmaceutical industry's growing attention to complex synthetic modalities and sophisticated small molecules demands that CDMOs upgrade their development and manufacturing capabilities and establish collaborative partnerships with innovators. Full article: https://lnkd.in/g3C3Dj7B